Endometrial cancer

The following is a summary of "Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial ...

Routine postoperative laboratory testing raised expenses without adding any clear therapeutic value, and they were unlikely to result in meaningful care changes for women receiving minimally invasive hysterectomies for endometrial cancer. The majority (91.4%) of the 649 women that were analyzed were White, with a mean age of 61 years and a mean body mass index of 38.0 kg/m2. The necessity and benefit of regular postoperative tests were uncertain given the rising rates of same-day discharge following minimally invasive surgery for endometrial cancer. 151 minutes was the median operating duration (the range was 61-278), and 100 mL (range, 10–1,500) was the median estimated blood loss. The following information was manually retrieved from the patient’s medical records: demographics, preoperative comorbidities, surgical and postoperative data, and pathologic results. Using cost information from hospitals, the financial burden of laboratory testing was calculated.